These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21168163)

  • 1. Editorial comment.
    Penson DF
    J Urol; 2011 Feb; 185(2):413-4; author reply 414. PubMed ID: 21168163
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment.
    Cost NG; Margulis V
    J Urol; 2011 Feb; 185(2):413; author reply 414. PubMed ID: 21168168
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of patients with small renal masses: a survey of the American Urological Association.
    Breau RH; Crispen PL; Jenkins SM; Blute ML; Leibovich BC
    J Urol; 2011 Feb; 185(2):407-13. PubMed ID: 21168170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Matthew N. Simmons, Benjamin I. Chung, Inderbir S. Gill. Perioperative efficacy of laparoscopic partial nephrectomy for tumors larger than 4 cm. Eur Urol 2009;55:199-208.
    Baumert H
    Eur Urol; 2009 Jun; 55(6):e103; author reply e104. PubMed ID: 19249152
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial comment.
    Russo P
    Urology; 2009 May; 73(5):1082. PubMed ID: 19394510
    [No Abstract]   [Full Text] [Related]  

  • 6. Expanding the indications of partial nephrectomy.
    Rogers CG
    Eur Urol; 2011 Jun; 59(6):938-9. PubMed ID: 21440982
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial comment on: Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan.
    Autorino R; Falsaperla M
    Eur Urol; 2009 Jun; 55(6):1408. PubMed ID: 19299070
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial comment on: Factors predicting health-related quality of life recovery in patients undergoing surgical treatment for renal tumors: prospective evaluation using the RAND SF-36 Health Survey.
    Zigeuner R
    Eur Urol; 2010 Jan; 57(1):121-2. PubMed ID: 19406564
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial comment on: Factors predicting health-related quality of life recovery in patients undergoing surgical treatment for renal tumors: prospective evaluation using the RAND SF-36 Health Survey.
    Terrone C
    Eur Urol; 2010 Jan; 57(1):120-1. PubMed ID: 19406566
    [No Abstract]   [Full Text] [Related]  

  • 10. Positive margins after nephron-sparing surgery for renal cell carcinoma: long-term follow-up of patients on active surveillance.
    Lopez-Costea MA; Fumadó L; Lorente D; Riera L; Miranda EF
    BJU Int; 2010 Sep; 106(5):645-8. PubMed ID: 20067450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
    La Rochelle J; Shuch B; Riggs S; Liang LJ; Saadat A; Kabbinavar F; Pantuck A; Belldegrun A
    J Urol; 2009 May; 181(5):2037-42; discussion 2043. PubMed ID: 19298974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal surgery--is technique more important than tumor or patient characteristics in preserving kidney function?
    Goldfarb DA
    J Urol; 2011 Feb; 185(2):383-4. PubMed ID: 21168169
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial comment on: Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan.
    Patel HR
    Eur Urol; 2009 Jun; 55(6):1407. PubMed ID: 19299074
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cancer of the kidney in adults. Treatment of the localized stage].
    Prog Urol; 1997 Nov; 7(5):843-57. PubMed ID: 9458482
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial comment.
    Russo P
    Urology; 2010 Feb; 75(2):275-6; author reply 276. PubMed ID: 20152477
    [No Abstract]   [Full Text] [Related]  

  • 16. Laparoscopic radical versus partial nephrectomy for tumors >4 cm: intermediate-term oncologic and functional outcomes.
    Simmons MN; Weight CJ; Gill IS
    Urology; 2009 May; 73(5):1077-82. PubMed ID: 19394509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial comment on: external validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Blute ML
    Eur Urol; 2010 Jan; 57(1):110-1. PubMed ID: 19062158
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial comment on: External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Giannarini G; Autorino R
    Eur Urol; 2010 Jan; 57(1):109-10. PubMed ID: 19062156
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcomes following partial nephrectomy by tumor size.
    Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
    J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Carcinoma of the kidney in the adult: results of current treatment. 120 cases (author's transl)].
    Cukier J; Amiel JL; Bronstein M; Droz JP
    Nouv Presse Med; 1979 Jan; 8(5):319-21. PubMed ID: 554090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.